![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
20
Technology In Biomaterials, S.l. Barcelona Es, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Bovine hydroxyapatite, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2014-069 - Rev 00
This TSE Type CEP, issued on October 22, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.